SCHEMBL26434993

SCHEMBL26434993

c1ccc2c(-c3ccc(-c4nc(-c5cccc6c5oc5ccccc56)nc(-c5cccc6ccc7ccccc7c56)n4)cc3)cccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
MAPT P10636 6/20 0.39
KDM4E B2RXH2 6/20 0.39
ALDH1A1 P00352 6/20 0.39
HSD17B10 Q99714 5/20 0.39
HPGD P15428 4/20 0.39
ENPP3 O14638 1/20 0.39
ENPP1 P22413 1/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TP53 P04637 2/20 0.38
ATM Q13315 2/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435705 0.97 ALOX5 (0.44) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26435023 0.96 ALOX5 (0.48) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26435678 0.95 ALOX5 (0.44) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26435694 0.95 ALOX5 (0.46) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26435010 0.94 ALOX5 (0.43) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26434970 0.94 ALOX5 (0.43) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26434963 0.94 ALOX5 (0.42) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26435673 0.93 ALOX5 (0.44) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL26434966 0.92 ALOX5 (0.43) ALOX5MAPTKDM4EALDH1A1HSD17B10
SCHEMBL22889112 0.92 ALOX5 (0.50) ALOX5MAPTKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885MAPT 2425/4885KDM4E 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.